ATA903993A - Pth-analoga - Google Patents
Pth-analogaInfo
- Publication number
- ATA903993A ATA903993A AT0903993A AT903993A ATA903993A AT A903993 A ATA903993 A AT A903993A AT 0903993 A AT0903993 A AT 0903993A AT 903993 A AT903993 A AT 903993A AT A903993 A ATA903993 A AT A903993A
- Authority
- AT
- Austria
- Prior art keywords
- pth analog
- pth
- analog
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10211—Podoviridae
- C12N2795/10222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Physical Education & Sports Medicine (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929215009A GB9215009D0 (en) | 1992-07-15 | 1992-07-15 | Organic compounds |
GB929226415A GB9226415D0 (en) | 1992-12-18 | 1992-12-18 | Organic compounds |
GB929226861A GB9226861D0 (en) | 1992-12-23 | 1992-12-23 | Organic compounds |
GB929226859A GB9226859D0 (en) | 1992-12-23 | 1992-12-23 | Organic compounds |
GB939301691A GB9301691D0 (en) | 1993-01-28 | 1993-01-28 | Organic compounds |
GB939301692A GB9301692D0 (en) | 1993-01-28 | 1993-01-28 | Organic compounds |
GB939307673A GB9307673D0 (en) | 1993-04-14 | 1993-04-14 | Organic compounds |
GB939308033A GB9308033D0 (en) | 1993-04-19 | 1993-04-19 | Organic compounds |
PCT/EP1993/001749 WO1994002510A2 (en) | 1992-07-15 | 1993-07-06 | Analogs of pth |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA903993A true ATA903993A (de) | 2001-01-15 |
AT408100B AT408100B (de) | 2001-08-27 |
Family
ID=27571302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0903993A AT408100B (de) | 1992-07-15 | 1993-07-06 | Pth-analoga |
Country Status (25)
Country | Link |
---|---|
US (2) | US20050009147A1 (de) |
EP (1) | EP0672057B1 (de) |
JP (1) | JP3164463B2 (de) |
KR (1) | KR100321651B1 (de) |
CN (1) | CN1051769C (de) |
AT (1) | AT408100B (de) |
AU (1) | AU672790B2 (de) |
CA (1) | CA2100423C (de) |
CH (1) | CH688195A5 (de) |
CZ (1) | CZ286889B6 (de) |
DE (2) | DE4393381T1 (de) |
DK (1) | DK0672057T3 (de) |
ES (1) | ES2150948T3 (de) |
FI (1) | FI113872B (de) |
GB (1) | GB2269176B (de) |
GR (1) | GR3035089T3 (de) |
HK (1) | HK1004896A1 (de) |
HU (2) | HUT70459A (de) |
IL (1) | IL106326A (de) |
NO (1) | NO319448B1 (de) |
NZ (1) | NZ248137A (de) |
PT (1) | PT672057E (de) |
SG (1) | SG63625A1 (de) |
SK (1) | SK283485B6 (de) |
WO (1) | WO1994002510A2 (de) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5814603A (en) * | 1992-06-12 | 1998-09-29 | Affymax Technologies N.V. | Compounds with PTH activity |
WO1995011697A1 (fr) * | 1993-10-27 | 1995-05-04 | Chugai Seiyaku Kabushiki Kaisha | Accelerateur de guerison utilise en chondroplastie |
US6110892A (en) * | 1994-06-20 | 2000-08-29 | National Research Council Of Canada | Parathyroid hormone analogues for the treatment of osteoporosis |
US5955425A (en) * | 1996-08-02 | 1999-09-21 | National Research Council Of Canada | Parathyroid hormone analogues for the treatment of osteoporosis |
CA2126299C (en) * | 1994-06-20 | 2000-12-12 | Gordon E. Willick | Parathyroid hormone analogues for the treatment of osteoporosis |
CO4410206A1 (es) * | 1994-07-28 | 1997-01-09 | Sandoz Ag | DERIVADOS DE PTH o PTHrP, SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN |
US5747456A (en) * | 1994-12-19 | 1998-05-05 | Beth Israel Deaconess Medical Center | Continuous low-dose administration of parathyroid hormone or its agonist |
CA2178894A1 (en) * | 1995-06-15 | 1996-12-16 | Tsunehiko Fukuda | Parathyroid hormone derivatives and their use |
US5969095A (en) * | 1995-07-13 | 1999-10-19 | Biomeasure, Inc. | Analogs of parathyroid hormone |
US6544949B1 (en) | 1995-07-13 | 2003-04-08 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Analogs of parathyroid hormone |
US5723577A (en) * | 1995-07-13 | 1998-03-03 | Biomeasure Inc. | Analogs of parathyroid hormone |
US7410948B2 (en) | 1995-07-13 | 2008-08-12 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Analogs of parathyroid hormone |
US5955574A (en) * | 1995-07-13 | 1999-09-21 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. | Analogs of parathyroid hormone |
ES2207740T3 (es) * | 1996-08-02 | 2004-06-01 | National Research Council Of Canada | Analogo de la hormona paratiroide para el tratamiento de la osteoporosis. |
EP1352912A1 (de) * | 1996-08-02 | 2003-10-15 | National Research Council Of Canada | Analoge des Parathormons zur Behandlung der Osteoporose |
EP0986395A4 (de) | 1997-05-14 | 2004-12-01 | Aventis Pharm Prod Inc | Peptidanaloge des parathyroidhormons |
WO1999004808A1 (fr) * | 1997-07-22 | 1999-02-04 | Chugai Seiyaku Kabushiki Kaisha | Medicaments dentaires contenant de la pth |
JP2002509854A (ja) * | 1997-09-09 | 2002-04-02 | エフ.ホフマン−ラ ロシュ アーゲー | PTHrP類似体を使用する骨折治癒 |
JP4460157B2 (ja) | 1998-05-05 | 2010-05-12 | イプセン・ファルマ・ソシエテ・パ・アクシオンス・シンプリフィエ | Pth2レセプター選択的化合物 |
US6495662B1 (en) | 1998-10-22 | 2002-12-17 | The General Hospital Corporation | Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) |
JP4486258B2 (ja) | 1998-11-25 | 2010-06-23 | ザ・ジェネラル・ホスピタル・コーポレイション | ヒト副甲状腺ホルモンの改変、調製および使用 |
ATE403678T1 (de) * | 1998-12-31 | 2008-08-15 | Gen Hospital Corp | Peptide, bestehend aus zwei funktionellen pth- domänen, die durch ein linkermolekül verknüpft sind, und derivate davon |
EP1141237B1 (de) | 1998-12-31 | 2005-11-02 | The General Hospital Corporation | Pth rezeptor und testverfahren unter verwendung desselben |
US7057012B1 (en) | 1998-12-31 | 2006-06-06 | The General Hospital Corporation | PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
US20050272652A1 (en) * | 1999-03-29 | 2005-12-08 | Gault Victor A | Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity |
DE19916419B4 (de) * | 1999-04-08 | 2005-06-16 | Schering Ag | Kombinationspräparat aus Vitamin-D-Metaboliten oder Vitamin-D-Analoga und einem Östrogenpartialagonisten zur Behandlung von Osteoporose |
WO2001023521A2 (en) | 1999-09-29 | 2001-04-05 | The General Hospital Corporation | Polypeptide derivatives of parathyroid hormone (pth) |
US7572765B2 (en) | 2001-07-23 | 2009-08-11 | The General Hospital Corporation | Conformationally constrained parathyroid hormone (PTH) analogs |
WO2003059291A2 (en) | 2002-01-10 | 2003-07-24 | Osteotrophin Llc | Treatment of bone disorders with skeletal anabolic drugs |
GB0205693D0 (en) * | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
EP1513547A4 (de) | 2002-05-23 | 2009-11-04 | Michael F Holick | Verwendung von parathormone-peptid-analoga zur behandlung von scheidenatrophie |
AU2002951372A0 (en) * | 2002-09-13 | 2002-09-26 | St Vincent's Institute Of Medical Research | Parathyroid hormone-like polypeptides |
EP2201960A1 (de) * | 2003-03-19 | 2010-06-30 | The General Hospital Corporation | Konformationseingeschränkte Parathormone mit Alpha-Helix-Stabilisatoren |
JP4871128B2 (ja) | 2003-07-17 | 2012-02-08 | ザ ジェネラル ホスピタル コーポレイション | 高次構造的に制約された副甲状腺ホルモン(pth)アナログ |
US9046537B2 (en) | 2003-09-22 | 2015-06-02 | Enzo Biochem, Inc. | Method for treating inflammation by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain |
MXPA06013168A (es) | 2004-05-13 | 2007-05-15 | Johnson & Johnson | Aparato y metodo para el suministro transdermico de agentes de la hormona paratiroidea. |
US9052324B2 (en) | 2004-05-19 | 2015-06-09 | Enzo Biochem, Inc. | Compounds and assays for controlling Wnt activity |
SG159551A1 (en) | 2005-02-11 | 2010-03-30 | Amylin Pharmaceuticals Inc | Gip analog and hybrid polypeptides with selectable properties |
US8263545B2 (en) | 2005-02-11 | 2012-09-11 | Amylin Pharmaceuticals, Inc. | GIP analog and hybrid polypeptides with selectable properties |
US20090170762A1 (en) * | 2005-09-08 | 2009-07-02 | Uutech Limited | Treatment of Diabetes Related Obesity |
EP1937716A2 (de) * | 2005-09-08 | 2008-07-02 | Uutech Limited | Analoga des gastric inhibitory polypeptide als behandlung für die altersbedingte verminderte pankreas-betazellen-funktion |
BRPI0618469A2 (pt) * | 2005-11-10 | 2011-08-30 | Univ Michigan Tech | hormÈnio paratiróide de urso preto e métodos de uso de hormÈnio paratiróide de urso preto |
WO2008019062A2 (en) * | 2006-08-04 | 2008-02-14 | The General Hospital Corporation | Polypeptide derivatives of parathyroid hormone (pth) |
US8497240B2 (en) | 2006-08-17 | 2013-07-30 | Amylin Pharmaceuticals, Llc | DPP-IV resistant GIP hybrid polypeptides with selectable properties |
EA014696B1 (ru) | 2006-10-13 | 2010-12-30 | Эли Лилли Энд Компани | Пэгилированный паратиреоидный гормон в качестве модулятора рецептора паратиреоидного гормона и его применение |
MX353986B (es) | 2007-08-01 | 2017-11-06 | Massachusetts Gen Hospital | Metodos de analisis y seleccion usando receptores acoplados a proteina g y composiciones relacionadas. |
JP6265583B2 (ja) | 2008-10-17 | 2018-01-24 | ウィスコンシン アルムニ リサーチ ファンデイション | 生理活性アルファベータペプチドを作製する方法 |
WO2010111617A2 (en) | 2009-03-27 | 2010-09-30 | Van Andel Research Institute | Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use |
CA2782640A1 (en) | 2009-12-07 | 2011-06-16 | Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
MX358161B (es) | 2010-05-13 | 2018-08-06 | The General Hospital Corp Star | Analogos de hormona paratiroidea y usos para los mismos. |
US8609621B2 (en) | 2010-11-15 | 2013-12-17 | E I Du Pont De Nemours And Company | Acid-cleavable linkers exhibiting altered rates of acid hydrolysis |
CN103501801A (zh) * | 2011-03-01 | 2014-01-08 | 索隆-基特林癌症研究协会 | 甲状旁腺激素类似物、其组合物和用途 |
US20170037086A1 (en) * | 2014-04-09 | 2017-02-09 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles with pth activity |
TW202421630A (zh) | 2018-12-20 | 2024-06-01 | 美商Ksq治療公司 | 經取代之吡唑并嘧啶及經取代之嘌呤以及其作為泛素特異性加工蛋白酶1(usp1)抑制劑的用途 |
AU2021371305A1 (en) | 2020-10-30 | 2023-06-15 | KSQ Therapeutics, Inc. | Solid state forms of substituted pyrazolopyrimidines and uses thereof |
WO2023066881A1 (en) | 2021-10-18 | 2023-04-27 | Astrazeneca Ab | Inhibition of map3k15 for treating and preventing diabetes |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3886132A (en) * | 1972-12-21 | 1975-05-27 | Us Health | Human parathyroid hormone |
US4423037A (en) * | 1982-05-13 | 1983-12-27 | The General Hospital Corporation | Inhibitors of peptide hormone action |
FR2550204B1 (fr) * | 1983-08-05 | 1987-11-13 | Toyo Jozo Kk | Derives peptidiques de (nle8,nle1b, tyr34)-h-pth |
US4752585A (en) * | 1985-12-17 | 1988-06-21 | Cetus Corporation | Oxidation-resistant muteins |
US5420242A (en) * | 1986-10-22 | 1995-05-30 | Kaare M. Gautvik | Production of human parathyroid hormone from microorganisms |
US5001223A (en) * | 1987-05-26 | 1991-03-19 | Merck & Co., Inc. | Parathyroid hormone antagonists with enhanced metabolic properties |
EP0293158A3 (de) * | 1987-05-26 | 1990-05-09 | Merck & Co. Inc. | Parathyroide Hormon-Antagonisten |
US4771124A (en) * | 1987-05-26 | 1988-09-13 | Merck & Co., Inc. | Parathyroid hormone antagonists with simplified synthetic methodology |
DE3725320A1 (de) * | 1987-07-30 | 1989-02-09 | Biotechnolog Forschung Gmbh | Expressionsvektoren und verfahren unter deren verwendung zur gewinnung von cro/ss-galaktosidase/pth-fusionsproteinen und von pth |
US4968669A (en) * | 1988-05-09 | 1990-11-06 | Merck & Co., Inc. | Parathyroid hormone antagonists |
WO1990010067A1 (de) * | 1989-02-23 | 1990-09-07 | GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) | Pth-varianten kodierende dna-sequenzen, pth-varianten, expressionsvektor, bakterieller wirt, verwendung und therapeutische zusammensetzung |
CA2040264A1 (en) * | 1990-04-12 | 1991-10-13 | Tatsuhiko Kanmera | Parathyroid hormone antagonists |
US5093233A (en) * | 1990-04-25 | 1992-03-03 | Merck & Co., Inc. | Antagonists with position 13 modification |
GB9020544D0 (en) * | 1990-09-20 | 1990-10-31 | Sandoz Ltd | Improvements in or relating to organic compounds |
JPH0532696A (ja) * | 1990-09-28 | 1993-02-09 | Takeda Chem Ind Ltd | 副甲状腺ホルモン誘導体 |
CA2098283A1 (en) * | 1990-12-21 | 1992-06-22 | Richard P. Bozzato | Oxidation resistant variants of parathyroid hormone |
ES2087323T3 (es) * | 1991-02-19 | 1996-07-16 | Takeda Chemical Industries Ltd | Metodo para producir peptidos exentos de cisteina. |
US5317010A (en) * | 1991-10-10 | 1994-05-31 | Peter K. T. Pang | Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment |
US5434246A (en) * | 1992-03-19 | 1995-07-18 | Takeda Chemical Industries, Ltd. | Parathyroid hormone derivatives |
US5382658A (en) * | 1992-04-03 | 1995-01-17 | Allelix Biopharmaceuticals Inc. | Stability-enhanced variants of parathyroid hormone |
US5589452A (en) * | 1992-07-14 | 1996-12-31 | Syntex (U.S.A.) Inc. | Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
-
1993
- 1993-06-29 AU AU41566/93A patent/AU672790B2/en not_active Ceased
- 1993-07-06 DK DK93915814T patent/DK0672057T3/da active
- 1993-07-06 DE DE4393381T patent/DE4393381T1/de not_active Withdrawn
- 1993-07-06 AT AT0903993A patent/AT408100B/de not_active IP Right Cessation
- 1993-07-06 PT PT93915814T patent/PT672057E/pt unknown
- 1993-07-06 DE DE4393381A patent/DE4393381B4/de not_active Expired - Lifetime
- 1993-07-06 SK SK43-95A patent/SK283485B6/sk unknown
- 1993-07-06 HU HU9500115A patent/HUT70459A/hu unknown
- 1993-07-06 CZ CZ199588A patent/CZ286889B6/cs not_active IP Right Cessation
- 1993-07-06 EP EP93915814A patent/EP0672057B1/de not_active Expired - Lifetime
- 1993-07-06 WO PCT/EP1993/001749 patent/WO1994002510A2/en active IP Right Grant
- 1993-07-06 CH CH00784/94A patent/CH688195A5/de not_active IP Right Cessation
- 1993-07-06 ES ES93915814T patent/ES2150948T3/es not_active Expired - Lifetime
- 1993-07-12 GB GB9314384A patent/GB2269176B/en not_active Expired - Fee Related
- 1993-07-12 SG SG1996008052A patent/SG63625A1/en unknown
- 1993-07-13 NZ NZ248137A patent/NZ248137A/en not_active IP Right Cessation
- 1993-07-13 CA CA002100423A patent/CA2100423C/en not_active Expired - Fee Related
- 1993-07-13 IL IL106326A patent/IL106326A/xx not_active IP Right Cessation
- 1993-07-14 JP JP17416393A patent/JP3164463B2/ja not_active Expired - Fee Related
- 1993-07-14 CN CN93116483A patent/CN1051769C/zh not_active Expired - Fee Related
- 1993-07-14 KR KR1019930013440A patent/KR100321651B1/ko not_active IP Right Cessation
-
1995
- 1995-01-12 NO NO19950123A patent/NO319448B1/no unknown
- 1995-01-13 FI FI950171A patent/FI113872B/fi not_active IP Right Cessation
- 1995-06-21 HU HU95P/P00320P patent/HU211856A9/hu unknown
-
1998
- 1998-05-12 HK HK98104077A patent/HK1004896A1/xx not_active IP Right Cessation
-
2000
- 2000-12-15 GR GR20000402777T patent/GR3035089T3/el unknown
-
2004
- 2004-05-18 US US10/848,279 patent/US20050009147A1/en not_active Abandoned
-
2008
- 2008-07-08 US US12/169,134 patent/US20080318838A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATA903993A (de) | Pth-analoga | |
DE59303358D1 (de) | Quaterrylentetracarbonsäureimide | |
DE59306810D1 (de) | Gutbettwalzenmühle | |
FI931536A0 (fi) | Antikontamineringsbehandling foer papperstillverkningsvaevnader | |
DE59302851D1 (de) | Sportschuh | |
BR9305745A (pt) | Quebra-luz | |
DE59305364D1 (de) | Rotornut | |
DE59304139D1 (de) | Polyanile | |
BR9301712A (pt) | Aplainador | |
ATA227792A (de) | Sportschuh | |
DE59301762D1 (de) | Chlorethylsulfonylbenzaldehyde | |
PT8484T (pt) | Sacarrolhas aperfeicoado | |
DE59206388D1 (de) | Kabeleckkanal | |
BR9200296A (pt) | Varre-lava | |
BR9203234A (pt) | Sofa-mesa | |
BR7200879U (pt) | Cocho saleiro biazi | |
BR7201352U (pt) | Luninaria | |
BR7201859U (pt) | Cambao | |
BR7202026U (pt) | Aero-mala | |
BR9200231A (pt) | Agrupador | |
BR9200295A (pt) | Aurissima | |
BR7200240U (pt) | Vari-watt | |
BR9200298A (pt) | Microsisten-telesupervisao | |
BR9200554A (pt) | Lixoduto | |
BR9200611A (pt) | Hidrocofre |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee |